{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:13:44Z","timestamp":1791530024845,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10792-019-01240-3","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T03:02:23Z","timestamp":1575342143000},"page":"795-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6669-5202","authenticated-orcid":false,"given":"Ufuk","family":"Elgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Ozdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufer","family":"Berker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2012.04.006","volume":"58","author":"SS Siddique","year":"2013","unstructured":"Siddique SS, Suelves AM, Baheti U, Foster CS (2013) Glaucoma and uveitis. Surv Ophthalmol 58:1\u201310","journal-title":"Surv Ophthalmol"},{"key":"1240_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/09273948.2015.1047036","volume":"24","author":"K Al Rubaie","year":"2016","unstructured":"Al Rubaie K, Al Dhahri H, Al Fawaz A et al (2016) Incidence and risk factors for developing glaucoma among patients with uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 24:571\u2013578","journal-title":"Ocul Immunol Inflamm"},{"key":"1240_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajo.2009.04.007","volume":"148","author":"I Tugal-Tutkun","year":"2009","unstructured":"Tugal-Tutkun I, G\u00fcney-Tefekli E, Kamaci-Duman F, Corum I (2009) A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol 148:510\u2013515","journal-title":"Am J Ophthalmol"},{"key":"1240_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4274\/tjo.99897","volume":"46","author":"P Nal\u00e7ac\u0131o\u011flu","year":"2016","unstructured":"Nal\u00e7ac\u0131o\u011flu P, \u00c7akar \u00d6zdal P, \u015eim\u015fek M (2016) Clinical characteristics of Fuchs\u2019 uveitis syndrome. Turk J Ophthalmol 46:52\u201357","journal-title":"Turk J Ophthalmol"},{"key":"1240_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-0420.2007.00990.x","volume":"86","author":"K Norrsell","year":"2008","unstructured":"Norrsell K, Sj\u00f6dell L (2008) Fuchs\u2019 heterochromic uveitis: a longitudinal clinical study. Acta Ophthalmol 86:58\u201364","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"1240_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/09273948.2016.1199712","volume":"25","author":"JT Toniolo","year":"2017","unstructured":"Toniolo JT, Hall AJ, Smith JG, Levy J, Lim LL (2017) Risk factors for glaucoma in a cohort of patients with Fuchs heterochromic iridocyclitis. Ocul Immunol Inflamm 25(6):753\u2013759","journal-title":"Ocul Immunol Inflamm"},{"key":"1240_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.ijg.0000435774.97407.67","volume":"24","author":"DK Hwang","year":"2015","unstructured":"Hwang DK, Chou YJ, Pu CY, Chou P (2015) Risk factors for developing glaucoma among patients with uveitis: a nation wide study in Taiwan. J Glaucoma 24:219\u2013224","journal-title":"J Glaucoma"},{"issue":"4","key":"1240_CR8","doi-asserted-by":"publisher","first-page":"CD011599","DOI":"10.1002\/14651858.cd011599.pub2","volume":"18","author":"H Mehta","year":"2018","unstructured":"Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S (2018) Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database Syst Rev 18(4):CD011599. https:\/\/doi.org\/10.1002\/14651858.cd011599.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3928\/23258160-20180221-03","volume":"49","author":"M Ashraf","year":"2018","unstructured":"Ashraf M, Banaee T, Silva FQ, Singh RP (2018) Switching anti-vascular endothelial growth factors in refractory neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 49:166\u2013170","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"1240_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/02713683.2016.1164188","volume":"42","author":"J Kaushik","year":"2017","unstructured":"Kaushik J, Parihar JK, Jain VK et al (2017) Efficacy of bevacizumab compared to mitomycin C modulated trabeculectomy in primary open angle glaucoma: a one-year prospective randomized controlled study. Curr Eye Res 42:217\u2013224","journal-title":"Curr Eye Res"},{"key":"1240_CR11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/IJG.0000000000000741","volume":"26","author":"Z Vahedian","year":"2017","unstructured":"Vahedian Z, Mafi M, Fakhraie G et al (2017) Short- term results of trabeculectomy using adjunctive intracameral bevacizumab versus mitomycin C: a randomized controlled trial. J Glaucoma 26:829\u2013834","journal-title":"J Glaucoma"},{"issue":"6","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10792-018-0926-y","volume":"39","author":"U Elgin","year":"2019","unstructured":"Elgin U, Sen E, \u00c7olak S, Yilmazbas P (2019) Initial trabeculectomy with 5-fluorouracil with or without subconjunctival bevacizumab in the management of pseudoexfoliation glaucoma. Int Ophthalmol 39(6):1211\u20131217","journal-title":"Int Ophthalmol"},{"key":"1240_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/ceo.12097","volume":"41","author":"LI De Fendi","year":"2013","unstructured":"De Fendi LI, Arruda GV, Scott IU, Paula JS (2013) Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials. Clin Exp Ophthalmol 41:798\u2013806","journal-title":"Clin Exp Ophthalmol"},{"key":"1240_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/IJG.0b013e318255dc07","volume":"22","author":"A Chawla","year":"2013","unstructured":"Chawla A, Mercieca K, Fenerty C, Jones NP (2013) Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis. J Glaucoma 22:663\u2013666","journal-title":"J Glaucoma"},{"issue":"6","key":"1240_CR15","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s10792-017-0737-6","volume":"38","author":"FA Almobarak","year":"2018","unstructured":"Almobarak FA, Alharbi AH, Morales J, Aljadaan I (2018) The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma. Int Ophthalmol 38(6):2371\u20132379","journal-title":"Int Ophthalmol"},{"key":"1240_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/IJG.0000000000000384","volume":"25","author":"FA Almobarak","year":"2016","unstructured":"Almobarak FA, Alharbi AH, Morales J, Aljadaan I (2016) Outcomes of trabeculectomy with mitomycin-C in uveitis associated with Vogt\u2013Koyanagi\u2013Harada Disease. J Glaucoma 25:528\u2013532","journal-title":"J Glaucoma"},{"key":"1240_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/IJG.0000000000000665","volume":"26","author":"K Komae","year":"2017","unstructured":"Komae K, Takamoto M, Tanaka R et al (2017) Initial trabeculectomy with mitomycin-C for secondary glaucoma-associated with Uveitis in Beh\u00e7et disease patients. J Glaucoma 26:603\u2013607","journal-title":"J Glaucoma"},{"key":"1240_CR18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00417-013-2312-9","volume":"251","author":"YA You","year":"2013","unstructured":"You YA, Wu Y, Hu S (2013) Surgical management of secondary glaucoma in Fuchs\u2019 heterochromic iridocyclitis. Graefes Arch Clin Exp Ophthalmol 251:1785\u20131790","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1240_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3109\/02713683.2013.851704","volume":"39","author":"C Ozgonul","year":"2014","unstructured":"Ozgonul C, Mumcuoglu T, Gunal A (2014) The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model. Curr Eye Res 39:451\u2013459","journal-title":"Curr Eye Res"},{"key":"1240_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/IJG.0b013e31829f9bd3","volume":"24","author":"TY Tai","year":"2015","unstructured":"Tai TY, Moster MR, Pro MJ, Myers JS, Katz LJ (2015) Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs. J Glaucoma 24:311\u2013315","journal-title":"J Glaucoma"},{"key":"1240_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1089\/jop.2012.0035","volume":"28","author":"T Simsek","year":"2012","unstructured":"Simsek T, Cankaya AB, Elgin U (2012) Comparison of needle revision with subconjunctival bevacizumab and 5- fluorouracil injection of failed trabeculectomy blebs. J Ocul Pharmacol Ther 28:542\u2013546","journal-title":"J Ocul Pharmacol Ther"},{"key":"1240_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/IJG.0000000000000195","volume":"24","author":"DI Bettis","year":"2015","unstructured":"Bettis DI, Morshedi RG, Chaya C, Goldsmith J, Crandall A, Zabriskie N (2015) Trabeculectomy with mitomycin C or Ahmed valve implantation in eyes with uveitic glaucoma. J Glaucoma 24:591\u2013599","journal-title":"J Glaucoma"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-019-01240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T12:59:47Z","timestamp":1665147587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-019-01240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s10792-019-01240-3","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Our presentation was approved by Ethics Committee of Numune Training and Research Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was taken from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}